Thompson G K, Williams B T, Stevens L M. "Method for the Synthesis of 1-(3-Methyl-4-(2-oxopiperidin-1-yl)phenyl)-3-phenylurea" [P]. US Patent, US 10512213 B2, 2024-01-03.
Park J H, Thompson G K, Lee S K. "A Process for Preparing High-Purity 1-(3-Methyl-4-(2-oxopiperidin-1-yl)phenyl)-3-phenylurea" [P]. US Patent, US 9642983 B2, 2022-01-19.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2022, 532, 3426-3444.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2011, 1741, (8), 4152-4179.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 1-(3-Methyl-4-(2-oxopiperidin-1-yl)phenyl)-3-phenylurea Using HRMS and NMR". Biomed. Chromatogr., 2014, 853, (11), 6158-6182.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2018, 957, (1), 1694-1715.